Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| PE2R4 | P35408 | Prostaglandin E2 receptor EP4 subtype (PGE receptor EP4 subtype) (PGE2 receptor EP4 subtype) (Prostanoid EP4 receptor) | 7 | AbortionArterial occlusive diseaseCoronary atherosclerosis | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 2 | 0.40 | |||
| PIGN | O95427 | GPI ethanolamine phosphate transferase 1 (EC 2.-.-.-) (GPI-ethanolamine transferase I) (GPI-ETI) (MCD4 homolog) (Phosphatidylinositol-glycan biosynthesis class N protein) (PIG-N) | Disease related genesHuman disease related genesMetabolic proteins | 15 | Epilepsy | Metabolism mediation | 2 | 0.40 | ||
| PLAP | Q9Y263 | Phospholipase A-2-activating protein (PLA2P) (PLAP) | Disease related genesHuman disease related genesPlasma proteins | Intellectual disability | Fusion and delivery mediationImmune mediationMetabolism mediation | 2 | 0.40 | |||
| PLSI | Q14651 | Plastin-1 (Intestine-specific plastin) (I-plastin) | Disease related genesHuman disease related genesPredicted intracellular proteins | DeafnessNon-syndromic deafness | Fusion and delivery mediation | 2 | 0.40 | |||
| PSCA | O43653 | Prostate stem cell antigen | Cancer-related genesPredicted intracellular proteinsPredicted membrane proteins | Non-small-cell lung cancerPancreatic cancerProstate cancer | Clinical-translation mediationMetabolism mediationReceptor-signaling mediation | 2 | 0.40 | |||
| PTAFR | P25105 | Platelet-activating factor receptor (PAF-R) (PAFr) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Allergic/hypersensitivity disorderAsthmaCardiac arrhythmia | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 2 | 0.40 | ||
| RAPSN | Q13702 | 43 kDa receptor-associated protein of the synapse (RAPsyn) (43 kDa postsynaptic protein) (Acetylcholine receptor-associated 43 kDa protein) (RING finger protein 205) | Disease related genesHuman disease related genesPredicted intracellular proteins | Congenital myasthenic syndrome | Adhesion and uptake mediation | 2 | 0.40 | |||
| RHOA | P61586 | Transforming protein RhoA (EC 3.6.5.2) (Rho cDNA clone 12) (h12) | Cancer-related genesDisease related genesEnzymes | Ectodermal dysplasiaSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 2 | 0.40 | |||
| S12A6 | Q9UHW9 | Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3) | Disease related genesHuman disease related genesMetabolic proteins | 12 | Charcot-Marie-Tooth disease | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 2 | 0.40 | ||
| S13A5 | Q86YT5 | Na(+)/citrate cotransporter (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter) (Solute carrier family 13 member 5) | Disease related genesHuman disease related genesMetabolic proteins | 11 | Amelogenesis imperfectaEpilepsy | Fusion and delivery mediation | 2 | 0.40 |